Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL

NCT: NCT06258707 · RECRUITING

NCT IDNCT06258707
StatusRECRUITING
Start Date2024-10-14
Completion2028-06-15
SponsorCutting Edge SAS (INDUSTRY)
First posted
Last updated

Brief Summary

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxBoost intraocular lenses compared with the LuxGood Monofocal lens.

Frequently Asked Questions

What is Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL?

Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL is a clinical trial registered under NCT06258707. Current status: RECRUITING.

What is the status of NCT06258707?

The current status of NCT06258707 (Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL) is: RECRUITING.

When did Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL start?

Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL started on 2024-10-14.

Related Devices

PMA P060011intraocular lensRayner Intraocular Lenses , Ltd. PMA P080004intraocular lensHoya Surgical Optics, Inc. PMA P090022intraocular lensLenstec, Inc. PMA P100016intraocular lensCarl Zeiss Meditec Production, LLC PMA P190018intraocular lensAlcon Laboratories, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑